article thumbnail

Pharma must embrace an AI future says new report

Drug Discovery World

Artificial intelligence (AI) technology has the potential to revolutionise drug discovery and pharma companies need to make plans for a future in which AI is frequently utilised in research, says ResearchAndMarkets.com.

article thumbnail

How AI in pharma can live up to the hype 

Drug Discovery World

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. According to Hampleton Patners’ latest Healthtech M&A market report2, digital health companies raised a total of $57.2

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Disrupting the CRO Model: Altasciences Participates in Documentary Series for 2024 Global Health Summit

Alta Sciences

Watch Altasciences in "Flipping the Drug Development Industry on Its Head" A Brief History of the CRO Market Contract Research Organizations (CROs) first entered the pharma world in the 1970s. CROs have historically functioned as auxiliaries to pharma companies, conducting the work sponsors can’t do in-house.

article thumbnail

India: Why is the country ramping up drug discovery research?

Drug Discovery World

DDW’s Megan Thomas takes a deeper look into why India is ramping up drug discovery research, and explores the country’s innovation hubs of interest. According to a report by Deloitte, globally India is the third largest in the world by volume and 11th by value, comprising over 3,000 pharma companies and 10,500 manufacturing facilities 2.

Research 130